linkedin post 2013-01-31 05:48:16

Uncategorized
BETTER TO FAIL TRYING THE IMPOSSIBLE THAN TO NEVER TRY. Conversations with entrepreneurs and mentors alike usually return to a central theme: it is a really exciting, interesting and somewhat crazy lifestyle, but once tasted, most people never go back to the steady workforce. They make themselves unemployable except in these high-octane environments. The second theme is always a great pride in changing the world, one brick at a time, and creating something out of nothing. View in LinkedIn
Read More

linkedin post 2013-02-01 06:13:07

Uncategorized
WHY SETTING UP A FOREIGN OFFICE MATTERS. For example: you are an emerging European company seeking foreign financing, because it is a dry well in Europe. You target US VCs. Guess what? Unless you are in an easy travel radius from their offices, not a prayer. Set up a Palo Alto office, so you can meet them on their doorstep, hold future board meetings there, and so on. Instantly remove the first objection to saying yes. A US subsidiary may also make you eligible for US grants and other money. View in LinkedIn
Read More

linkedin post 2013-02-01 05:49:03

Uncategorized
FIRST IN CLASS, AND BEST OF BREED are common terms in Biopharma business presentations. The First in Class refers to a novel Mechanism of Action (MOA), and Best of Breed to ranking in a class of the same molecular targets. The first is a disruptive innovation at a molecular level, identifying a novel target, while the second is an incremental improvement on known targets. Both the disruptive and incremental advances can score tremendous valuations, illustrating that disruptive is not the only legitimate goal for entrepreneurs or investors. View in LinkedIn
Read More

linkedin post 2013-02-02 03:44:42

Uncategorized
STARTING YOUR OWN BUSINESS? Read this article on negotiating, because this one activity probably will occupy the bulk of your working time. You will negotiate with your team, your landlord, your vendors, your board, your investors, and do not forget -- your family. Your job is to continually find the middle ground and wisest course between competing options. http://lnkd.in/3CS3ck View in LinkedIn
Read More

linkedin post 2013-02-02 03:17:44

Uncategorized
2012 BIO TRENDS are looking positive overall and it seems that the nuclear winter of the past few years is thawing. Investor optimism will likely continue to be driven by liquidity events through M&As and IPOs. As usual, the US is the leader of these trends, with a lag in Europe, which has a much thinner VC and IPO base. http://lnkd.in/UEsQFb View in LinkedIn
Read More

linkedin post 2013-02-01 17:25:25

Uncategorized
BIOPHARMA IS A FORMIDABLE ECONOMIC ENGINE OF GROWTH. "The biotech industry is a key driver of modern economic progress" (Battell, 2098). Although only about forty years old, by 2015 it is predicted to exceed 320 B USD in sales, and generate well over 1 M skilled well-paying jobs. Considering that the global Pharma industry is driven by only about 370 new drugs approved in the past decade, it is clear that the room for growth is considerable. View in LinkedIn
Read More